Integral Derivatives’s Biogen BIIB Stock Holding History

Integral Derivatives’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$574K	Buy	+2,095	New	+$650K	0.01%	355
2017 Q2	–	Sell	-8,749	Closed	-$2.31M	–	1094
2017 Q1	$2.39M	Sell	8,749 -683	-7%	-$193K	0.04%	267
2016 Q4	$2.67M	Buy	9,432 +900	+11%	+$267K	0.05%	253
2016 Q3	$2.67M	Sell	8,532 -3,750	-31%	-$1.11M	0.06%	209
2016 Q2	$2.97M	Buy	12,282 +6,278	+105%	+$1.65M	0.07%	165
2016 Q1	$1.56M	Buy	+6,004	New	+$1.59M	0.05%	269
2015 Q4	–	Sell	-12,110	Closed	-$3.48M	–	1069
2015 Q3	$3.53M	Buy	12,110 +4,499	+59%	+$1.49M	0.1%	174
2015 Q2	$3.07M	Buy	7,611 +1,265	+20%	+$508K	0.08%	214
2015 Q1	$2.68M	Sell	6,346 -7,549	-54%	-$2.98M	0.06%	216
2014 Q4	$4.72M	Buy	13,895 +1,230	+10%	+$398K	0.08%	206
2014 Q3	$4.19M	Buy	+12,665	New	+$4.18M	0.07%	231

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Integral Derivatives's BIIB Position: Q1 2018 in Review

Integral Derivatives opened a new position in Biogen (BIIB) in Q1 2018: 2,095 shares worth $574K. The stake represents 0.01% of the portfolio and ranks #355 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in BIIB as recently as Q1 2017.

Integral Derivatives first reported a position in BIIB in Q3 2014 and has held it in 11 quarters since. The position peaked at $4.72M in Q4 2014. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

Integral Derivatives held 2,095 shares of Biogen worth $574K as of Q1 2018.
Biogen was a new Integral Derivatives position in Q1 2018.
Biogen made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #355 holding.
Integral Derivatives first reported a position in Biogen in Q3 2014 and has held it in 11 quarters since.
Integral Derivatives's Biogen position peaked at $4.72M in Q4 2014.
1,102 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.